Kristen Deak to Mutation
This is a "connection" page, showing publications Kristen Deak has written about Mutation.
Connection Strength
0.386
-
Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4. Neurology. 2007 Feb 20; 68(8):578-82.
Score: 0.108
-
Blast Phase of Myeloproliferative Neoplasm Resembles Acute Myeloid Leukemia, Myelodysplasia-Related, in Clinical Presentation, Cytogenetic Pattern, and Genomic Profile, and Often Undergoes Reversion to Second Chronic Phase Status After Induction Chemotherapy. Arch Pathol Lab Med. 2024 12 01; 148(12):1310-1319.
Score: 0.094
-
Acute myeloid leukemia arising from polycythemia vera underwent reversion to chronic phase of myeloproliferative neoplasm status post chemotherapy: Biclonal myeloid neoplasms with genomic evidence of a common early hematopoietic progenitor. Hematol Oncol. 2021 Apr; 39(2):254-257.
Score: 0.071
-
CSGALNACT1-congenital disorder of glycosylation: A mild skeletal dysplasia with advanced bone age. Hum Mutat. 2020 03; 41(3):655-667.
Score: 0.066
-
Automated next-generation profiling of genomic alterations in human cancers. Nat Commun. 2022 05 20; 13(1):2830.
Score: 0.020
-
Pulmonary Granular Cell Tumors: A Study of 4 Cases Including a Malignant Phenotype. Am J Surg Pathol. 2019 10; 43(10):1397-1402.
Score: 0.016
-
False positives in multiplex PCR-based next-generation sequencing have unique signatures. J Mol Diagn. 2014 Sep; 16(5):541-549.
Score: 0.011